Country: France
Language: English
Source: HMA (Heads of Medicines Agencies)
oxantel embonate 200.28 mg, praziquantel 50 mg, pyrantel embonate 49.94 mg
Vetoquinol
QP52AA51
Tablet
praziquantel, combinations
Dogs
2011-09-30
SEPTEMBER 2011 1/10 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT France EXETEC 10 United-Kingdom The Blue Cross – Dog Wormer for medium dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substances Oxantel 200.28 mg (equivalent to 559 mg of oxantel embonate) Pyrantel 49.94 mg (equivalent to 144 mg of pyrantel embonate) Praziquantel 50.00 mg Excipient to one 950 mg divisible tablet Excipients For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow, oblong tablet with breaking line 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: _ _ _ _ _Toxocara canis _ _ _ _ _ _Toxascaris leonina_ _ _ _ _ _Ancylostoma caninum_ _ _ _ _ _Uncinaria stenocephala_ _ _ _ _ _Trichuris vulpis_ Cestodes: _ _ _ _ _Dipylidium caninum _ _ _ _ _ _Taenia _spp _ _ _ _ _ _ _Echinococcus multilocularis_ _ _ _ _ _Echinococcus granulosus _ 4.3 CONTRAINDICATIONS See section 4.8 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class Fleas serve as intermediate hosts for one of the common tapeworms – _Dipylidium caninum_. Tapeworm infestation may reoccur unless control of intermediate hosts Read the complete document